AAA
SYRS

Affinity Asset Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Affinity Asset Advisors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$34.5K – 107
2024
Q4 		$34.5K Buy
+150,000
New +$34.5K ﹤0.01% 74
2024
Q3 		– Hold
0
– – – 103